Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 9/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.76 |
| ▸ | MAPT | P10636 | 8/20 | 0.76 |
| ▸ | POLB | P06746 | 7/20 | 0.76 |
| ▸ | USP2 | O75604 | 7/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.76 |
| ▸ | BLM | P54132 | 6/20 | 0.76 |
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.76 |
| ▸ | GAA | P10253 | 5/20 | 0.76 |
| ▸ | RECQL | P46063 | 5/20 | 0.76 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.76 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.76 |
| ▸ | THRB | P10828 | 4/20 | 0.76 |
| ▸ | ACHE | P22303 | 1/20 | 0.71 |
| ▸ | MET | P08581 | 1/20 | 0.67 |
| ▸ | HPGD | P15428 | 7/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.65 |
| ▸ | ALOX12 | P18054 | 4/20 | 0.65 |
| ▸ | TP53 | P04637 | 4/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29588932 | 1.00 | MEN1 (0.76) | MEN1KMT2AMAPTPOLBUSP2 | |
| SCHEMBL18079541 | 0.88 | MAPT (0.60) | MEN1KMT2AMAPTPOLBUSP2 | |
| SCHEMBL29407268 | 0.87 | ACHE (0.69) | MEN1KMT2AMAPTPOLBUSP2 | |
| SCHEMBL31400944 | 0.86 | ACHE (0.72) | MEN1KMT2AMAPTPOLBUSP2 | |
| SCHEMBL31481983 | 0.86 | MEN1 (0.61) | MEN1KMT2AMAPTPOLBUSP2 | |
| SCHEMBL31481984 | 0.86 | MEN1 (0.61) | MEN1KMT2AMAPTPOLBUSP2 | |
| SCHEMBL30319388 | 0.86 | MEN1 (1.00) | MEN1KMT2AMAPTPOLBUSP2 | |
| SCHEMBL30367913 | 0.86 | MEN1 (1.00) | MEN1KMT2AMAPTPOLBUSP2 | |
| SCHEMBL13320834 | 0.86 | MEN1 (1.00) | MEN1KMT2AMAPTPOLBUSP2 | |
| SCHEMBL19636311 | 0.83 | ACHE (1.00) | MEN1KMT2AMAPTPOLBUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5176977-A | Carrier particles, toner of colorant and a mixture of nonpolymeric, thermoplastic compounds as binder | EASTMAN KODAK COMPANY (US) | 1993-01-05 | — | — | US | claimed |
| EP-0118881-B1 | BINDER-MIXTURES FOR OPTICAL RECORDING LAYERS AND ELEMENTS | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1988-09-14 | — | — | EP | claimed |
| US-4626361-A | Binder-mixtures for optical recording layers and elements | EASTMAN KODAK COMPANY (US) | 1986-12-02 | — | — | US | claimed |
| EP-0118881-A2 | Binder-mixtures for optical recording layers and elements | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1984-09-19 | — | — | EP | claimed |
| CN-106471094-B | Pi-conjugated semiconductor organic glass mixture for OLED and OED | 分子玻璃公司 | 2021-04-20 | — | — | CN | disclosed |
| EP-3083881-B1 | MOLECULAR GLASS MIXTURES FOR ORGANIC ELECTRONICS APPLICATIONS | MOLECULAR GLASSES INC (US) | 2020-09-09 | — | — | EP | disclosed |
| US-10593886-B2 | OLED devices with improved lifetime using non-crystallizable molecular glass mixture hosts | MOLECULAR GLASSES, INC. (US) | 2020-03-17 | — | — | US | disclosed |
| US-10589003-B2 | Methods for coating surfaces with antimicrobial agents | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2020-03-17 | — | — | US | disclosed |
| US-10461269-B2 | Crosslinkable, /polymerizable and combinations thereof charge-transporting molecular glass mixtures, luminescent molecular glass mixtures, or combinations thereof for organic light emitting diodes and other organic electronics and photonics applications and method of making same | MOLECULAR GLASSES, INC. (US) | 2019-10-29 | — | — | US | disclosed |
| US-10329542-B2 | HBV RNAse H purification and enzyme inhibitors | SAINT LOUIS UNIVERSITY (US) | 2019-06-25 | — | — | US | disclosed |
| US-10240084-B2 | Non-crystallizable pi-conjugated molecular glass mixtures, charge transporting molecular glass mixtures, luminescent molecular glass mixtures, or combinations thereof for organic light emitting diodes and other organic electronics and photonics applications | MOLECULAR GLASSES, INC. (US) | 2019-03-26 | — | — | US | disclosed |
| US-10211409-B2 | Noncrystallizable sensitized layers for OLED and OEDs | MOLECULAR GLASSES, INC. (US) | 2019-02-19 | — | — | US | disclosed |
| EP-0355387-A2 | Photopolymerisable mixture and recording material manufactured therefrom | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-02-28 | — | — | EP | disclosed |
| EP-0321827-A2 | Photopolymerisable mixture and recording material manufactured therefrom | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-06-28 | — | — | EP | disclosed |
| EP-0321826-A2 | Photopolymerisable mixture and recording material manufactured therefrom | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-06-28 | — | — | EP | disclosed |
| EP-0287817-A2 | Photopolymerisable composition and registration material prepared therewith | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-10-26 | — | — | EP | disclosed |
| EP-0284938-A2 | Photopolymerisable composition and registration material prepared therewith | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-10-05 | — | — | EP | disclosed |
| US-4626361-A | Binder-mixtures for optical recording layers and elements | EASTMAN KODAK COMPANY (US) | 1986-12-02 | — | — | US | disclosed |
| US-4499165-A | COMPATABILITY; STABILITY; LASERS; DATA PROCESSING | EASTMAN KODAK COMPANY (US) | 1985-02-12 | — | — | US | disclosed |
| EP-0118881-A2 | Binder-mixtures for optical recording layers and elements | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1984-09-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10589003-B2 | Methods for coating surfaces with antimicrobial agents | CUTA, CD63, CDC37 | MEN1 4111/4885KMT2A 3316/4885MAPT 3347/4885 |
| US-10329542-B2 | HBV RNAse H purification and enzyme inhibitors | RNASEH1, RNASE1, RNASEL | MEN1 2978/4885KMT2A 2785/4885MAPT 4504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.